← Explore

Ultrasound modulates microglial activity and reduces neuroinflammation in a parameter-dependent manner

Sarina Grewal, Francesco Iacoponi, Lok Yin Nicholas Chan, Valeria Dosso, William Lim Kee Chang, Vanessa Drevenakova, Albert Ugwudike, Leonardo Ricotti, Paul M. Matthews, Andrea Cafarelli, Sophie V. Morse

npj Acoustics 2026 · 10.1038/s44384-026-00047-8

in vitro cellrodentsystemic inflammationhistology molecular

Abstract

Neuroinflammation contributes to the progression of many neurological diseases. Here, we explore whether ultrasound can reduce microglia-mediated inflammation in vitro and in vivo. We tested a broad range of ultrasound parameters in a BV2 microglial cell line, treated with lipopolysaccharide (LPS) to induce an inflammatory response. We found that specific combinations of centre frequency, acoustic pressure and treatment duration can significantly lower the levels of pro-inflammatory cytokines, including tumor necrosis factor (TNF)-α, interleukin (IL)-1β and IL-6. These effects lasted up to 72 h and were associated with the downregulation of the nuclear factor κB (NF-κB), suggesting a mechanistic link between ultrasound and inflammation. Further investigation in vivo, in LPS-treated mice, revealed a reduction in TNF-α expression in the hippocampus following ultrasound. Overall, our findings showcase the potential of ultrasound as a non-invasive therapeutic strategy to reduce neuroinflammation and restore brain homeostasis.

Abstract via europepmc.

Speciesmouse (C57BL/6; BV2 murine microglial cell line)
Subjects4 animals
Sessions per subject1
Randomisedyes
Blindingnot reported
Sham / controlinactive transducer
Auditory controlnot reported
Readout timingoffline
Anaesthesiaanaesthetised
Readoutshistology molecular — ELISA (TNF-alpha, IL-1beta, IL-6, IL-4); RT-qPCR; LDH assay; Iba1 and CD68 immunostaining; thermocouple temperature
Direction of effectnot assessedUltrasound reduced pro-inflammatory cytokines in LPS-treated BV2 cells in a frequency-dependent way (strongest at 2 and 0.5 MHz) and reduced hippocampal TNF-alpha and Iba1 optical density in LPS mice 4 h after treatment.
Adverse eventsnot reportedIn vitro temperature rise below 2 C except 2.1 C at 0.5 MHz, 0.4 MPa, 60 min; LDH release reduced; k-Wave simulation gave skull temperature rise about 0.013 C for the in vivo parameters.

Exposures

Exposure 1: BV2 microglia in vitro, 0.5/1/2 MHz

Target: cultured glia — “BV2 microglial cell line”
Device: other named manufacturer · Precision Acoustics · unfocused piezoelectric transducers, 0.5 MHz (44 mm), 1 MHz (23 mm), 2 MHz (23 mm) ✓

Pulse timing
Waveformpulsed
Fundamental frequency (kHz)500, 1,000, 2,000swept✓✓✓
Pulse duration (ms)not reportedimplied by duty cycle ÷ PRF: 0.2 ms (not stated by the paper)⚑
Pulse repetition frequency (Hz)1,000✓✓✓
Duty cycle (%)20✓✓✓
Sonication duration (s)300, 1,800, 3,600swept✓✓✓⚑
Pressure and intensity, by domain
Free-field pressure (kPa)not reported
Free-field Isppa (W/cm²)not reported
Free-field Ispta (W/cm²)not reported
In-situ estimatenot applicable
In-situ pressure (kPa)not applicable
In-situ Isppa (W/cm²)not applicable
In-situ Ispta (W/cm²)not applicable
Pressure, domain unspecified (kPa)100, 200, 400swept✓✓✓⚑
Protocol, in the paper’s words

Single treatment of LPS-treated BV2 cells at 3 frequencies, 3 peak-to-peak pressures and 3 durations (5, 30, 60 min), duty cycle 20% and PRF 1 kHz; supernatant collected 24 h later.

Exposure 2: Whole-brain sonication of LPS mice, 0.5 MHz

Target: whole brain or unfocused — “whole mouse brain”
Device: Sonic Concepts · Sonic Concepts · H-107 ✓

Pulse timing
Waveformpulsed
Fundamental frequency (kHz)500✓✓✓
Pulse duration (ms)0.2✓✓✓
Pulse repetition frequency (Hz)1,000✓✓✓
Duty cycle (%)20pulse duration × PRF gives 20%✓✓✓⚑
Sonication duration (s)6✓✓✓
Pressure and intensity, by domain
Free-field pressure (kPa)200✓✓✓⚑
Free-field Isppa (W/cm²)not reported
Free-field Ispta (W/cm²)not reported
In-situ estimatenot reported
In-situ pressure (kPa)not reported
In-situ Isppa (W/cm²)not reported
In-situ Ispta (W/cm²)not reported
Protocol, in the paper’s words

6 s sonication at each point of a grid (8.52 x 14.98 mm) covering the whole brain, 200 microsecond pulses at 1 kHz; a single treatment on day 7, brains collected 4 h later.

Flags from extraction

  • n_subjects — Mice: saline 3, LPS 4, LPS + ultrasound 4 (11 total, stated as 'Eleven'); in vitro n = 3 wells per condition. Only 4 mice received ultrasound.
  • exposures[0].unspecified_domain.pressure_kpa — Stated as peak-to-peak pressure 0.1, 0.2, 0.4 MPa; domain not stated (in vitro device). Intensities only in Supplementary Table S1.
  • exposures[0].timing.pulse_duration_ms — Pulse duration not stated for in vitro exposure; not computed from duty cycle and PRF.
  • exposures[0].timing.sonication_duration_s — Durations 5, 30, 60 min converted to seconds; a full factorial of 3 frequencies x 3 pressures x 3 durations is one exposure with lists.
  • exposures[1].free_field.pressure_kpa — 0.2 MPa quoted from the acoustic simulation methods (pressure at focus in water); in vivo methods state 0.2 MPa acoustic pressure without domain.
  • exposures[1].timing.duty_cycle_pct — Duty cycle stated in the thermal simulation methods as 20%, matching the in vivo parameters.
  • exposures[1].target.terms — Whole brain covered by raster of a focused beam over an 8.52 x 14.98 mm grid, 6 s per point.
  • direction_of_effect — Outcomes are cytokines and microglial morphology, not neural excitability.